ID   CT26
AC   CVCL_7254
SY   CT-26; CT 26; Colon Tumor 26
DR   BTO; BTO:0003630
DR   BioGRID_ORCS_Cell_line; 1261
DR   ChEMBL-Cells; CHEMBL3308079
DR   ChEMBL-Targets; CHEMBL613866
DR   KCB; KCB 2012007YJ
DR   KCLB; 80009
DR   Lonza; 1686
DR   NCBI_Iran; C532
DR   PubChem_Cell_line; CVCL_7254
DR   TOKU-E; 4093
DR   Wikidata; Q54814707
RX   PubMed=6992981;
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-441.html
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from child cell line CT26.WT).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from child cell line CT26.WT).
CC   Transformant: ChEBI; CHEBI:82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 24
//
RX   PubMed=6992981;
RA   Brattain M.G., Strobel-Stevens J., Fine D., Webb M., Sarrif A.M.;
RT   "Establishment of mouse colonic carcinoma cell lines with different
RT   metastatic properties.";
RL   Cancer Res. 40:2142-2146(1980).
//